FDA Inspection 1318224 — Octapharma Plasma Inc

Octapharma Plasma Inc — FEI 3015775917

The FDA completed an inspection of Octapharma Plasma Inc on May 14, 2026 in Mesa, AZ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
May 14, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Mesa, AZ (United States)

Citations

IDCFRDescription
1503021 CFR 606.60(b)Equipment calibration frequency

Need the full FDA record for Octapharma Plasma Inc? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.